🇰🇷 Lerochol in South Korea

Lerochol (LERODALCIBEP) regulatory status in South Korea.

Marketing authorisation

MFDS

  • Marketing authorisation holder: LIB THERAPEUTICS, INC.
  • Status: likely_approved

Lerochol in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Metabolic approved in South Korea

Frequently asked questions

Is Lerochol approved in South Korea?

Yes. MFDS has authorised it.

Who is the marketing authorisation holder for Lerochol in South Korea?

LIB THERAPEUTICS, INC. holds the South Korean marketing authorisation.